I tend to agree with you, we will see the trial accelerate after the safety protocols are assessed and approved after current 23 patients are dosed.
Also, the two Western Australian hospitals Fiona Stanley and Sir Charles Gairdner are now dosing and AGN is based and well known in the local health system.
Ann: Phase 2 Stroke Clinical Trial Update, page-17
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
69.0¢ |
Change
0.010(1.47%) |
Mkt cap ! $88.38M | |||
| Open | High | Low | Value | Volume |
| 68.0¢ | 70.0¢ | 68.0¢ | $26.75K | 38.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12480 | 69.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 1499 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| AGN (ASX) Chart |